![]() |
|||||
|
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() |
Gene: CSNK1G2 |
Gene summary for CSNK1G2 |
![]() |
Gene information | Species | Human | Gene symbol | CSNK1G2 | Gene ID | 1455 |
Gene name | casein kinase 1 gamma 2 | |
Gene Alias | CK1g2 | |
Cytomap | 19p13.3 | |
Gene Type | protein-coding | GO ID | GO:0006464 | UniProtAcc | P78368 |
Top |
Malignant transformation analysis |
![]() |
![]() |
Entrez ID | Symbol | Replicates | Species | Organ | Tissue | Adj P-value | Log2FC | Malignancy |
1455 | CSNK1G2 | LZE4T | Human | Esophagus | ESCC | 2.44e-04 | 6.43e-02 | 0.0811 |
1455 | CSNK1G2 | LZE7T | Human | Esophagus | ESCC | 6.43e-08 | 1.76e-01 | 0.0667 |
1455 | CSNK1G2 | LZE8T | Human | Esophagus | ESCC | 4.60e-06 | 1.03e-01 | 0.067 |
1455 | CSNK1G2 | LZE20T | Human | Esophagus | ESCC | 3.93e-06 | 1.21e-01 | 0.0662 |
1455 | CSNK1G2 | LZE24T | Human | Esophagus | ESCC | 1.33e-10 | 2.09e-01 | 0.0596 |
1455 | CSNK1G2 | LZE21T | Human | Esophagus | ESCC | 1.28e-03 | 2.36e-01 | 0.0655 |
1455 | CSNK1G2 | P1T-E | Human | Esophagus | ESCC | 3.59e-20 | 6.02e-01 | 0.0875 |
1455 | CSNK1G2 | P2T-E | Human | Esophagus | ESCC | 3.42e-09 | 2.31e-01 | 0.1177 |
1455 | CSNK1G2 | P4T-E | Human | Esophagus | ESCC | 2.85e-20 | 2.90e-01 | 0.1323 |
1455 | CSNK1G2 | P5T-E | Human | Esophagus | ESCC | 8.91e-06 | 4.46e-02 | 0.1327 |
1455 | CSNK1G2 | P8T-E | Human | Esophagus | ESCC | 6.91e-07 | 5.58e-02 | 0.0889 |
1455 | CSNK1G2 | P9T-E | Human | Esophagus | ESCC | 2.96e-19 | 2.36e-01 | 0.1131 |
1455 | CSNK1G2 | P10T-E | Human | Esophagus | ESCC | 4.07e-20 | 4.06e-01 | 0.116 |
1455 | CSNK1G2 | P11T-E | Human | Esophagus | ESCC | 2.92e-08 | 2.00e-01 | 0.1426 |
1455 | CSNK1G2 | P12T-E | Human | Esophagus | ESCC | 5.55e-17 | 1.45e-01 | 0.1122 |
1455 | CSNK1G2 | P15T-E | Human | Esophagus | ESCC | 4.69e-14 | 2.02e-01 | 0.1149 |
1455 | CSNK1G2 | P16T-E | Human | Esophagus | ESCC | 8.39e-13 | 2.15e-01 | 0.1153 |
1455 | CSNK1G2 | P17T-E | Human | Esophagus | ESCC | 1.80e-02 | 1.14e-01 | 0.1278 |
1455 | CSNK1G2 | P20T-E | Human | Esophagus | ESCC | 3.30e-11 | 1.18e-01 | 0.1124 |
1455 | CSNK1G2 | P21T-E | Human | Esophagus | ESCC | 1.53e-10 | 2.26e-01 | 0.1617 |
Page: 1 2 3 4 5 6 7 |
![]() |
∗log2FC in expression of this searched gene in stem-like cells from each diseased tissue sample relative to stem-like cells in normal samples in each tissue plotted against the malignancy continuum. Samples are colored based on if they are from different disease stage. |
Top |
Malignant transformation related pathway analysis |
![]() |
![]() |
Tissue | Disease Stage | Enriched GO biological Processes |
Colorectum | AD | ![]() |
Colorectum | SER | ![]() |
Colorectum | MSS | ![]() |
Colorectum | MSI-H | ![]() |
Colorectum | FAP | ![]() |
∗Top 15 enriched GO BP terms are showed in the bar plot of each disease state in each tissue. Each row represents a significant GO biological process which is colored according to the -log10(p.adjust). |
Page: 1 2 3 4 5 6 7 8 9 |
![]() |
GO ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | Count |
GO:0030148 | Oral cavity | OSCC | sphingolipid biosynthetic process | 53/7305 | 103/18723 | 6.81e-03 | 2.53e-02 | 53 |
GO:001810514 | Oral cavity | EOLP | peptidyl-serine phosphorylation | 84/2218 | 315/18723 | 3.32e-13 | 1.05e-10 | 84 |
GO:001820914 | Oral cavity | EOLP | peptidyl-serine modification | 87/2218 | 338/18723 | 1.07e-12 | 2.46e-10 | 87 |
GO:001605523 | Oral cavity | EOLP | Wnt signaling pathway | 89/2218 | 444/18723 | 3.66e-07 | 1.06e-05 | 89 |
GO:019873823 | Oral cavity | EOLP | cell-cell signaling by wnt | 89/2218 | 446/18723 | 4.49e-07 | 1.25e-05 | 89 |
GO:003011123 | Oral cavity | EOLP | regulation of Wnt signaling pathway | 67/2218 | 328/18723 | 5.11e-06 | 1.04e-04 | 67 |
GO:009026323 | Oral cavity | EOLP | positive regulation of canonical Wnt signaling pathway | 29/2218 | 106/18723 | 1.04e-05 | 1.86e-04 | 29 |
GO:006082823 | Oral cavity | EOLP | regulation of canonical Wnt signaling pathway | 54/2218 | 253/18723 | 1.11e-05 | 1.95e-04 | 54 |
GO:003017715 | Oral cavity | EOLP | positive regulation of Wnt signaling pathway | 35/2218 | 140/18723 | 1.20e-05 | 2.07e-04 | 35 |
GO:004677713 | Oral cavity | EOLP | protein autophosphorylation | 49/2218 | 227/18723 | 2.04e-05 | 3.21e-04 | 49 |
GO:006007023 | Oral cavity | EOLP | canonical Wnt signaling pathway | 61/2218 | 303/18723 | 2.11e-05 | 3.28e-04 | 61 |
GO:001605532 | Oral cavity | NEOLP | Wnt signaling pathway | 93/2005 | 444/18723 | 1.35e-10 | 1.34e-08 | 93 |
GO:019873832 | Oral cavity | NEOLP | cell-cell signaling by wnt | 93/2005 | 446/18723 | 1.73e-10 | 1.66e-08 | 93 |
GO:001810522 | Oral cavity | NEOLP | peptidyl-serine phosphorylation | 70/2005 | 315/18723 | 1.97e-09 | 1.24e-07 | 70 |
GO:001820922 | Oral cavity | NEOLP | peptidyl-serine modification | 72/2005 | 338/18723 | 7.84e-09 | 4.09e-07 | 72 |
GO:003011131 | Oral cavity | NEOLP | regulation of Wnt signaling pathway | 70/2005 | 328/18723 | 1.17e-08 | 5.67e-07 | 70 |
GO:006082831 | Oral cavity | NEOLP | regulation of canonical Wnt signaling pathway | 55/2005 | 253/18723 | 2.23e-07 | 7.28e-06 | 55 |
GO:006007031 | Oral cavity | NEOLP | canonical Wnt signaling pathway | 62/2005 | 303/18723 | 3.79e-07 | 1.15e-05 | 62 |
GO:009026331 | Oral cavity | NEOLP | positive regulation of canonical Wnt signaling pathway | 29/2005 | 106/18723 | 1.40e-06 | 3.56e-05 | 29 |
GO:003017723 | Oral cavity | NEOLP | positive regulation of Wnt signaling pathway | 33/2005 | 140/18723 | 9.57e-06 | 1.82e-04 | 33 |
Page: 1 2 3 4 5 6 |
![]() |
Pathway ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | qvalue | Count |
Page: 1 |
Top |
Cell-cell communication analysis |
![]() |
Ligand | Receptor | LRpair | Pathway | Tissue | Disease Stage |
Page: 1 |
Top |
Single-cell gene regulatory network inference analysis |
![]() |
TF | Cell Type | Tissue | Disease Stage | Target Gene | RSS | Regulon Activity |
∗The dot plots of a searched regulon are shown for all cell subpopulations in each disease state of each tissue based on the regulon specific score inferred using pySCENIC and by calculating the average expression. |
Page: 1 |
Top |
Somatic mutation of malignant transformation related genes |
![]() |
Hugo Symbol | Variant Class | Variant Classification | dbSNP RS | HGVSc | HGVSp | HGVSp Short | SWISSPROT | BIOTYPE | SIFT | PolyPhen | Tumor Sample Barcode | Tissue | Histology | Sex | Age | Stage | Therapy Types | Drugs | Outcome |
CSNK1G2 | SNV | Missense_Mutation | novel | c.211T>C | p.Tyr71His | p.Y71H | P78368 | protein_coding | tolerated(0.61) | benign(0.02) | TCGA-AR-A2LL-01 | Breast | breast invasive carcinoma | Female | >=65 | I/II | Hormone Therapy | tamoxiphen | SD |
CSNK1G2 | SNV | Missense_Mutation | novel | c.1129N>C | p.Thr377Pro | p.T377P | P78368 | protein_coding | deleterious(0.01) | probably_damaging(0.953) | TCGA-BH-A1ET-01 | Breast | breast invasive carcinoma | Female | <65 | I/II | Unknown | Unknown | SD |
CSNK1G2 | SNV | Missense_Mutation | novel | c.595N>A | p.Glu199Lys | p.E199K | P78368 | protein_coding | tolerated(0.42) | possibly_damaging(0.862) | TCGA-2W-A8YY-01 | Cervix | cervical & endocervical cancer | Female | <65 | I/II | Chemotherapy | cisplatin | CR |
CSNK1G2 | deletion | Frame_Shift_Del | novel | c.111delN | p.Val39SerfsTer2 | p.V39Sfs*2 | P78368 | protein_coding | TCGA-VS-A94Z-01 | Cervix | cervical & endocervical cancer | Female | <65 | I/II | Chemotherapy | cisplatin | CR | ||
CSNK1G2 | SNV | Missense_Mutation | rs548764709 | c.233C>T | p.Pro78Leu | p.P78L | P78368 | protein_coding | deleterious(0) | possibly_damaging(0.591) | TCGA-AA-3947-01 | Colorectum | colon adenocarcinoma | Female | <65 | I/II | Unknown | Unknown | SD |
CSNK1G2 | SNV | Missense_Mutation | c.581N>C | p.Glu194Ala | p.E194A | P78368 | protein_coding | deleterious(0) | probably_damaging(0.998) | TCGA-AD-A5EJ-01 | Colorectum | colon adenocarcinoma | Female | >=65 | I/II | Unknown | Unknown | SD | |
CSNK1G2 | SNV | Missense_Mutation | c.883N>T | p.Arg295Trp | p.R295W | P78368 | protein_coding | deleterious(0.01) | possibly_damaging(0.742) | TCGA-AM-5821-01 | Colorectum | colon adenocarcinoma | Female | >=65 | I/II | Unknown | Unknown | SD | |
CSNK1G2 | SNV | Missense_Mutation | c.772N>A | p.Asp258Asn | p.D258N | P78368 | protein_coding | tolerated(0.05) | probably_damaging(0.96) | TCGA-CK-4951-01 | Colorectum | colon adenocarcinoma | Female | >=65 | I/II | Unknown | Unknown | PD | |
CSNK1G2 | SNV | Missense_Mutation | c.404G>T | p.Arg135Leu | p.R135L | P78368 | protein_coding | deleterious(0) | possibly_damaging(0.82) | TCGA-F4-6463-01 | Colorectum | colon adenocarcinoma | Male | <65 | I/II | Unknown | Unknown | SD | |
CSNK1G2 | SNV | Missense_Mutation | novel | c.829G>A | p.Glu277Lys | p.E277K | P78368 | protein_coding | tolerated(0.2) | probably_damaging(0.999) | TCGA-F5-6814-01 | Colorectum | rectum adenocarcinoma | Male | <65 | I/II | Unknown | Unknown | SD |
Page: 1 2 3 4 |
Top |
Related drugs of malignant transformation related genes |
![]() |
(DGIdb 4.0) |
Entrez ID | Symbol | Category | Interaction Types | Drug Claim Name | Drug Name | PMIDs |
1455 | CSNK1G2 | KINASE, SERINE THREONINE KINASE, ENZYME, DRUGGABLE GENOME | PHA-767491 | CHEMBL225519 | ||
1455 | CSNK1G2 | KINASE, SERINE THREONINE KINASE, ENZYME, DRUGGABLE GENOME | TAK-715 | TAK-715 | ||
1455 | CSNK1G2 | KINASE, SERINE THREONINE KINASE, ENZYME, DRUGGABLE GENOME | SP-600125 | SP-600125 | ||
1455 | CSNK1G2 | KINASE, SERINE THREONINE KINASE, ENZYME, DRUGGABLE GENOME | ALSTERPAULLONE | ALSTERPAULLONE | ||
1455 | CSNK1G2 | KINASE, SERINE THREONINE KINASE, ENZYME, DRUGGABLE GENOME | SB-220025 | SB-220025 | ||
1455 | CSNK1G2 | KINASE, SERINE THREONINE KINASE, ENZYME, DRUGGABLE GENOME | inhibitor | 249565834 | ||
1455 | CSNK1G2 | KINASE, SERINE THREONINE KINASE, ENZYME, DRUGGABLE GENOME | PF-562271 | PF-00562271 | ||
1455 | CSNK1G2 | KINASE, SERINE THREONINE KINASE, ENZYME, DRUGGABLE GENOME | SNS-314 | SNS-314 | ||
1455 | CSNK1G2 | KINASE, SERINE THREONINE KINASE, ENZYME, DRUGGABLE GENOME | LINIFANIB | LINIFANIB | ||
1455 | CSNK1G2 | KINASE, SERINE THREONINE KINASE, ENZYME, DRUGGABLE GENOME | CYC-116 | CYC-116 |
Page: 1 2 |